Scientech Research LLC’s Novartis NVS Stock Holding History

Scientech Research LLC’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,568	Closed	-$553K	–	762
2025 Q2	$553K	Buy	+4,568	New	+$515K	0.14%	309

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Scientech Research LLC's NVS Position: Q3 2025 in Review

Scientech Research LLC sold out of Novartis (NVS) in Q3 2025, closing a stake of 4,568 shares — an estimated $553K sold.

Scientech Research LLC first reported a position in NVS in Q2 2025 and held it in 1 quarter. The position peaked at $553K in Q2 2025. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

Scientech Research LLC reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
Scientech Research LLC sold 4,568 Novartis shares in Q3 2025, an estimated $553K.
Scientech Research LLC first reported a position in Novartis in Q2 2025 and held it in 1 quarter.
Scientech Research LLC's Novartis position peaked at $553K in Q2 2025.
1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Scientech Research LLC's 13F filing for Q3 2025, filed 14 Nov 2025.